|
|
|
|
Endo Pharmaceuticals Holdings Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new market report released ..
Endo Pharmaceuticals Holdings Inc.- Pharmaceuticals & Healthcare - Deals and Alliances Profile - new market report released Refer to a friend 2010-03-10 22:33:03 - Endo Pharmaceuticals Holdings Inc. - Pharmaceuticals & Healthcare - Deals and...
|
|
|
Myotonic Dystrophy: Research from State University of New York, Center of Excellence in Bioinformatics has provided new information about myotonic dystrophy
Today's Medical & Research News Myotonic Dystrophy Research from State University of New York, Center of Excellence in Bioinformatics has provided new information about myotonic dystrophy March 10th, 2010 Printer-Friendly Version City:Buffalo State:NY...
|
|
|
Domo Chemicals finalizes successful expansion investments with start-up of a new ammonium sulfate storing faci
- Domo Caproleuna GmbH, subsidiary of DOMO Chemicals, celebrates in Leuna (Saxony-Anhalt, Germany) the successful start-up of a new Ammonium Sulfate storage facility (investment of 30 million euro) with a capacity of 80.000 tons in the presence of the...
|
|
|
Fabrication of Anionic Sulfate-Functionalized Nanoparticles as an Immunosensor by Protein Immobilization
Anionic sulfate (SO4?)-functionalized polystyrene (PS) nanoparticles were prepared by the thermal decomposion of potassium persulfate (KPS) in the presence of sodium tetraborate via emulsion polymerization.The presence of a SO4? group at a solid/liquid...
|
|
|
The Use of Calcium Sulfate Impregnated With Vancomycin in the Treatment of Open Fractures of Long Bones: A Pre
Trauma By Xiaobing Cai, MD; Kaiwei Han, MD; Xiaoliang Cong, MD; Jinfang Cai, MD; Dake Tong, MD; Dong Han, MD; Yu Wang, MD; Baoqing Yu, MD ORTHOPEDICS 2010; 33:152 Abstract The purpose of this study was to investigate the effect of calcium sulfate impregnated...
|
|
|
Applications of Magnesium Sulfate in Obstetrics and Anesthesia
Barbosa FT et al.Magnesium sulfate has been used in obstetrics with good results, inhibiting premature labor and in the treatment of eclampsiaassociated seizures. Applications of Magnesium Sulfate in Obstetrics and Anesthesia.
|
|
|
Restoring Barrier Function To Acid Damaged Bladder By Intravesical Chondroitin Sulfate
UroToday.com Whether the so-called "GAG layer" found on the luminal surface of the bladder plays a role in bladder impermeability and whether its loss in interstitial cystitis (IC) is significant has been controversial.Electrophysiologic studies using Ussing...
|
|
|
Medical News: Restoring Barrier Function To Acid Damaged Bladder By Intravesical Chondroitin Sulfate
UroToday.com Whether the so-called "GAG layer" found on the luminal surface of the bladder plays a role in bladder impermeability and whether its loss in interstitial cystitis (IC) is significant has been controversial.Medical News: Restoring Barrier...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
Salix Pharmaceuticals, Ltd.(NASDAQ:SLXP) today announced that NASDAQ has halted trading of the Companys common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the efficacy and safety of the New Drug...
|
|
|
NASDAQ halts trading of Salix Pharmaceuticals stock, FDA Committee to discuss XIFAXAN NDA
Salix Pharmaceuticals, Ltd.(NASDAQ:SLXP) today announced that NASDAQ has halted trading of the Companys common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the efficacy and safety of the New Drug...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
RALEIGH, N.C.-- (BUSINESS WIRE) -- (NASDAQ:SLXP) today announced that NASDAQ has halted trading of the Companys common stock this morning.The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the efficacy and safety of the New...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd.(NASDAQ: SLXP) today announced that NASDAQ has halted trading of the Company?s common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
BusinessWire - Salix Pharmaceuticals, Ltd.(NASDAQ:SLXP) today announced that NASDAQ has halted trading of the Company's common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the efficacy and safety...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
Companies mentioned in this article: Salix Pharmaceuticals, Ltd.RALEIGH, N.C. -- (BUSINESS WIRE) -- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that NASDAQ has halted trading of the Companys common stock this morning. The Gastrointestinal...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
FDA Advisory Committee Reviewing XIFAXAN (rifaximin) Tablets, 550 mg NDA Buzz up!Companies: Related Quotes {"s" : "slxp","k" : "c10,l10,p20,t10","o" : "","j" : ""} RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd! (NASDAQ:SLXP - News) today...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
RALEIGH, N.C.- (Business Wire) Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that NASDAQ has halted trading of the Companys common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
RALEIGH, N.C.- (BUSINESS WIRE) - Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that NASDAQ has halted trading of the Company's common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
Salix Pharmaceuticals Ltd (SLXP) Stock Quote, Chart, News, Add to Watchlist Salix Pharmaceuticals, Ltd.SLXP today announced that NASDAQ has halted trading of the Companys common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
FDA Advisory Committee Reviewing XIFAXAN (rifaximin) Tablets, 550 mg NDA Salix Pharmaceuticals, Ltd.(NASDAQ:SLXP) today announced that NASDAQ has halted trading of the Company's common stock this morning. The Gastrointestinal Drugs Advisory Committee of...
|
|
|
Salix Pharmaceuticals Announces 4Q2009 and FY2009 Financial Results Conference Call and Webcast
- Salix Pharmaceuticals, Ltd.(NASDAQ:SLXP) today announced that the Company will report fourth quarter 2009 and full year 2009 financial results following the close of the U.S. financial markets on Tuesday, March 9, 2010. The Company will host a...
|
|
|
Salix Pharmaceuticals to Present at Three Investment Conferences in March
Salix Pharmaceuticals, Ltd.(NASDAQ: SLXP) today announced that the Company will present at three health care investment conferences during March 2010. Information on these conferences is provided below: RBC Capital Markets Healthcare Conference New York, N...
|
|
|
Salix Pharmaceuticals to Present at Three Investment Conferences in March
- Salix Pharmaceuticals, Ltd.(NASDAQ: SLXP) today announced that the Company will present at three health care investment conferences during March 2010. Information on these conferences is provided below: Interested parties can access a live audio web cast...
|
|
|
Salix Pharmaceuticals Announces4Q2009 and FY2009 Financial ResultsConference Call and Webcast
RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd.(NASDAQ: SLXP) today announced that the Company will report fourth quarter 2009 and full year 2009 financial results following the close of the U.S. financial markets on Tuesday, March 9, 2010.
|
|
|
Salix Pharmaceuticals Announces 4Q2009 and FY2009 Financial Results Conference Call and Webcast
RALEIGH, N.C.-- (BUSINESS WIRE) -- (NASDAQ:SLXP) today announced that the Company will report fourth quarter 2009 and full year 2009 financial results following the close of the U.S.financial markets on Tuesday, March 9, 2010. The Company will host a...
|
|
|
Salix Pharmaceuticals to Present at Three Investment Conferences in March
RALEIGH, N.C.-- (BUSINESS WIRE) -- (NASDAQ: SLXP) today announced that the Company will present at three health care investment conferences during March 2010.Information on these conferences is provided below: RBC Capital Markets Healthcare Conference New...
|
